A prospective evaluation of the CD14 C(-260)T gene polymorphism and the risk of myocardial infarction

Atherosclerosis

Volumn 154, Issue 3, 2001, Pages 699-702

  Zee, Robert Y L ^a   Lindpaintner, Klaus ^a   Struk, Berthold ^a   Hennekens, Charles H ^b   Ridker, Paul M ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

CD14; Myocardial infarction; Prospective study; Risk factors

Indexed keywords

CD14 ANTIGEN; LIPOPOLYSACCHARIDE;

ADULT; AGED; ALLELE; ARTICLE; CLINICAL FEATURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; EVALUATION; FOLLOW UP; GENETIC POLYMORPHISM; GENOTYPE; HEART INFARCTION; HUMAN; MALE; NORMAL HUMAN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RISK ASSESSMENT; RISK FACTOR; SMOKING HABIT;

ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, CD14; CASE-CONTROL STUDIES; COHORT STUDIES; DOUBLE-BLIND METHOD; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HOMOZYGOTE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; POLYMORPHISM, GENETIC; PROSPECTIVE STUDIES;

EID: 0035864619     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0021-9150(00)00698-5     Document Type: Article

References (11)

1. Atherosclerosis - An inflammatory disease
2. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men
3. C(-260)T polymorphism in the promoter of the CD14 monocyte receptor gene as a risk factor for myocardial infarction
4. A new promoter polymorphism in the gene of lipopolysaccharide receptor CD14 is associated with expired myocardial infarction in patients with low atherosclerotic risk profile
5. Polymorphism of the lipopolysaccharide receptor (CD14) and myocardial infarction. New evidence for a role of gram-negative bacterial infection?
6. Assessment of genetic markers for coronary thrombosis: Promise and precaution
7. Final report of the aspirin component of the ongoing physicians' health study
8. Clinical epidemiological quality in molecular genetic research: The need for methodological standards
9. Mutation in the gene coding for coagulation factor V and the risk of myocardial infarction, stroke, and venous thrombosis in apparently healthy men
10. G20210A mutation in prothrombin gene and risk of myocardial infarction, stroke, and venous thrombosis in a large cohort of US men
11. Prospective evaluation of the angiotensin-converting enzyme insertion/deletion polymorphism and the risk of stroke